193 related articles for article (PubMed ID: 11837468)
1. Glibenclamide vs gliclazide in reducing oxidative stress in patients of noninsulin dependent diabetes mellitus--a double blind randomized study.
Chugh SN; Dhawan R; Kishore K; Sharma A; Chugh K
J Assoc Physicians India; 2001 Aug; 49():803-7. PubMed ID: 11837468
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of oxidative stress in diabetes mellitus during uncontrolled and controlled state and after vitamin E supplementation.
Chugh SN; Kakkar R; Kalra S; Sharma A
J Assoc Physicians India; 1999 Apr; 47(4):380-3. PubMed ID: 10778519
[TBL] [Abstract][Full Text] [Related]
3. [Free radical scavenging activity of sulfonylureas: a clinical assessment of the effectiveness of gliclazide].
Jennings PE; Belch JJ
Ter Arkh; 2001; 73(4):27-31. PubMed ID: 11494442
[TBL] [Abstract][Full Text] [Related]
4. Association of gliclazide and left ventricular mass in type 2 diabetic patients.
Pan NH; Lee TM; Lin MS; Huang CL; Chang NC
Diabetes Res Clin Pract; 2006 Nov; 74(2):121-8. PubMed ID: 16631274
[TBL] [Abstract][Full Text] [Related]
5. A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.
Charbonnel BH; Matthews DR; Schernthaner G; Hanefeld M; Brunetti P;
Diabet Med; 2005 Apr; 22(4):399-405. PubMed ID: 15787663
[TBL] [Abstract][Full Text] [Related]
6. The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes).
Kardas P
Diabetes Obes Metab; 2005 Nov; 7(6):722-8. PubMed ID: 16219016
[TBL] [Abstract][Full Text] [Related]
7. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of gliclazide modified release compared with glibenclamide on endothelial activation and low-grade inflammation in patients with type 2 diabetes.
Räkel A; Renier G; Roussin A; Buithieu J; Mamputu JC; Serri O
Diabetes Obes Metab; 2007 Jan; 9(1):127-9. PubMed ID: 17199728
[No Abstract] [Full Text] [Related]
9. Effects of low-dose omega-3 fatty acid substitution in type-2 diabetes mellitus with special reference to oxidative stress--a prospective preliminary study.
Jain S; Gaiha M; Bhattacharjee J; Anuradha S
J Assoc Physicians India; 2002 Aug; 50():1028-33. PubMed ID: 12421024
[TBL] [Abstract][Full Text] [Related]
10. [A prospective randomized study of sulphonylureas therapeutic interchange in patients with type 2 diabetes mellitus].
Crespí Monjo M; Delgado Sánchez O; Ventayol Bosch P; Lafuente Fló A; Pinteño Blanco M; Escrivá Torralva A; Puigventós Latorre F; Martínez-López I
Farm Hosp; 2004; 28(6):426-32. PubMed ID: 15628945
[TBL] [Abstract][Full Text] [Related]
11. Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients.
Kigawa Y; Oba K; Futami-Suda S; Norose J; Yasuoka H; Suzuki K; Ouchi M; Watanabe K; Suzuki T; Nakano H
Geriatr Gerontol Int; 2008 Sep; 8(3):160-5. PubMed ID: 18821999
[TBL] [Abstract][Full Text] [Related]
12. Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects.
Formoso G; De Filippis EA; Michetti N; Di Fulvio P; Pandolfi A; Bucciarelli T; Ciabattoni G; Nicolucci A; Davì G; Consoli A
Diabetes Metab Res Rev; 2008; 24(3):231-7. PubMed ID: 17966969
[TBL] [Abstract][Full Text] [Related]
13. Forearm vascular reactivity is differentially influenced by gliclazide and glibenclamide in chronically treated type 2 diabetic patients.
Wascher TC; Boes U
Clin Physiol Funct Imaging; 2005 Jan; 25(1):40-6. PubMed ID: 15659079
[TBL] [Abstract][Full Text] [Related]
14. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients.
Peerapatdit T; Patchanans N; Likidlilid A; Poldee S; Sriratanasathavorn C
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S147-55. PubMed ID: 17718256
[TBL] [Abstract][Full Text] [Related]
15. Ineffectiveness of allopurinol in reduction of oxidative stress in diabetic patients; a randomized, double-blind placebo-controlled clinical trial.
Afshari M; Larijani B; Rezaie A; Mojtahedi A; Zamani MJ; Astanehi-Asghari F; Mostafalou S; Hosseinnezhad A; Heshmat R; Abdollahi M
Biomed Pharmacother; 2004 Dec; 58(10):546-50. PubMed ID: 15589061
[TBL] [Abstract][Full Text] [Related]
16. The effect of short-term glycemic regulation with gliclazide and metformin on postprandial lipemia.
Emral R; Köseoğlulari O; Tonyukuk V; Uysal AR; Kamel N; Corapçioğlu D
Exp Clin Endocrinol Diabetes; 2005 Feb; 113(2):80-4. PubMed ID: 15772898
[TBL] [Abstract][Full Text] [Related]
17. Effects of gliclazide on endothelial function in patients with newly diagnosed type 2 diabetes.
Chen LL; Yu F; Zeng TS; Liao YF; Li YM; Ding HC
Eur J Pharmacol; 2011 Jun; 659(2-3):296-301. PubMed ID: 21453695
[TBL] [Abstract][Full Text] [Related]
18. Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study.
Matthews DR; Charbonnel BH; Hanefeld M; Brunetti P; Schernthaner G
Diabetes Metab Res Rev; 2005; 21(2):167-74. PubMed ID: 15386821
[TBL] [Abstract][Full Text] [Related]
19. Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-related mortality.
Monami M; Balzi D; Lamanna C; Barchielli A; Masotti G; Buiatti E; Marchionni N; Mannucci E
Diabetes Metab Res Rev; 2007 Sep; 23(6):479-84. PubMed ID: 17385195
[TBL] [Abstract][Full Text] [Related]
20. Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls.
Neri S; Signorelli SS; Torrisi B; Pulvirenti D; Mauceri B; Abate G; Ignaccolo L; Bordonaro F; Cilio D; Calvagno S; Leotta C
Clin Ther; 2005 Nov; 27(11):1764-73. PubMed ID: 16368447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
